期刊: JOURNAL OF NEUROENDOCRINOLOGY, 2022; 34 (4)
Peptide receptor radionuclide therapy (Lu-177-DOTATATE) causes DNA strand breaks and has been validated for well-differentiated neuroendocrine tumor t......
期刊: JOURNAL OF NEUROENDOCRINOLOGY, 2022; 34 (12)
Pancreatic neuroendocrine tumor (pNET) is the most common subset (31.5%) of gastroenteropancreatic neuroendocrine tumor in China. Based on real-world ......
期刊: JOURNAL OF NEUROENDOCRINOLOGY, 2022; 34 (6)
Background The optimal duration of capecitabine combined with temozolomide (CapTem) for metastatic pancreatic neuroendocrine tumours (PanNETs) remains......
期刊: JOURNAL OF NEUROENDOCRINOLOGY, 2021; 33 (5)
The present study investigated the factors associated with recurrence during long-term follow-up in acromegaly and compared the recurrence rate betwee......